8.40
price up icon2.31%   0.19
after-market Handel nachbörslich: 8.01 -0.39 -4.64%
loading
Schlusskurs vom Vortag:
$8.21
Offen:
$8.4
24-Stunden-Volumen:
3,048
Relative Volume:
0.41
Marktkapitalisierung:
$1.55B
Einnahmen:
$630.00K
Nettoeinkommen (Verlust:
$5.72M
KGV:
-24.60
EPS:
-0.3415
Netto-Cashflow:
$-6.75M
1W Leistung:
-1.18%
1M Leistung:
+10.53%
6M Leistung:
+11.55%
1J Leistung:
-4.38%
1-Tages-Spanne:
Value
$8.40
$8.40
1-Wochen-Bereich:
Value
$8.19
$8.48
52-Wochen-Spanne:
Value
$6.51
$13.27

Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile

Name
Firmenname
Addex Therapeutics Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
2
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-22
Name
Neueste SEC-Einreichungen
Name
ADXN's Discussions on Twitter

Vergleichen Sie ADXN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADXN
Addex Therapeutics Ltd Adr
8.40 9.09M 630.00K 5.72M -6.75M -0.3415
Biotechnology icon
ONC
Beigene Ltd Adr
241.43 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.00 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.34 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.06 5.92B 0 -153.72M -103.81M -2.00

Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-31 Hochstufung H.C. Wainwright Neutral → Buy

Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten

pulisher
May 17, 2025

Addex Raises $10.0 Million In Equity Financing - Barchart.com

May 17, 2025
pulisher
Apr 28, 2025

Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks

Apr 28, 2025
pulisher
Apr 26, 2025

Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks

Apr 26, 2025
pulisher
Apr 24, 2025

META_TITLE_SECTORS - Yahoo Finance

Apr 24, 2025
pulisher
Apr 17, 2025

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 - GlobeNewswire Inc.

Apr 17, 2025
pulisher
Jan 09, 2025

Coincheck Group N.V (CNCK) produces promising results - US Post News

Jan 09, 2025
pulisher
Nov 27, 2024

Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance

Nov 27, 2024
pulisher
Nov 20, 2024

Addex Stock Soars on Crucial Update From Indivior Research Deal - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Golden Heaven Group secures investment of $25.2M - MSN

Nov 18, 2024
pulisher
Nov 11, 2024

Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance

Nov 11, 2024
pulisher
Nov 07, 2024

Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Oct 25, 2024

Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance

Oct 25, 2024
pulisher
Oct 08, 2024

Drug discovery and bringing new medicine to marketthe future of AI in pharma - OutSourcing-Pharma.com

Oct 08, 2024
pulisher
Oct 04, 2024

What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq

Oct 04, 2024
pulisher
Aug 27, 2024

Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder - Yahoo Finance

Aug 27, 2024
pulisher
Aug 21, 2024

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Aug 21, 2024
pulisher
May 06, 2024

LYRA Stock Quote Price and Forecast - CNN

May 06, 2024
pulisher
Nov 07, 2023

Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq

Nov 07, 2023
pulisher
May 10, 2023

Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com

May 10, 2023
pulisher
Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022
pulisher
Jun 17, 2022

Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq

Jun 17, 2022
pulisher
Jan 06, 2022

Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com

Jan 06, 2022
pulisher
Jul 25, 2017

ADXN Stock Price and Chart — SIX:ADXN - TradingView

Jul 25, 2017

Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
Kapitalisierung:     |  Volumen (24h):